T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$8.01B |
| 2 |
Amazon
AMZN
|
+$5.64B |
| 3 |
Danaher
DHR
|
+$4.2B |
| 4 |
Gilead Sciences
GILD
|
+$4.09B |
| 5 |
JPMorgan Chase
JPM
|
+$4.03B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 13.97% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.58% |
| 5 | Technology | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCR
1376
DELISTED
SIMCERE PHARMACEUTICAL GROUP, ADS
SCR
| $5.68M | ﹤0.01% |
+599,300
| New | +$5.54M |
|
1377
Ascent Industries
ACNT
$133M
| $5.68M | ﹤0.01% |
+365,576
| New | +$5.2M |
|
1378
Copart
CPRT
$26.8B
| $5.62M | ﹤0.01% |
+1,460,800
| New | +$6.21M |
|
1379
Bio-Rad Laboratories Class A
BIO
$9.68B
| $5.58M | ﹤0.01% |
+49,690
| New | +$5.83M |
|
1380
Revvity
RVTY
$13.1B
| $5.55M | ﹤0.01% |
+170,909
| New | +$5.59M |
|
|
MTEM
1381
DELISTED
Molecular Templates, Inc.
MTEM
| $5.55M | ﹤0.01% |
+6,400
| New | +$5.41M |
|
|
GRMN
1382
Garmin
GRMN
$59.8B
| $5.55M | ﹤0.01% |
+153,390
| New | +$5.33M |
|
|
WW
1383
DELISTED
WW International
WW
| $5.55M | ﹤0.01% |
+120,581
| New | +$5.26M |
|
1384
Nasdaq
NDAQ
$53.5B
| $5.54M | ﹤0.01% |
+506,970
| New | +$5.17M |
|
|
XOXO
1385
DELISTED
Xo Group Inc
XOXO
| $5.5M | ﹤0.01% |
+490,700
| New | +$5.28M |
|
|
FLIR
1386
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $5.46M | ﹤0.01% |
+202,410
| New | +$5.02M |
|
1387
TSMC
TSM
$2.23T
| $5.41M | ﹤0.01% |
+295,006
| New | +$5.43M |
|
1388
Abercrombie & Fitch
ANF
$4.99B
| $5.37M | ﹤0.01% |
+118,660
| New | +$5.84M |
|
|
HAWK
1389
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $5.32M | ﹤0.01% |
+229,300
| New | +$5.6M |
|
|
PDCO
1390
DELISTED
Patterson Companies, Inc.
PDCO
| $5.3M | ﹤0.01% |
+140,970
| New | +$5.37M |
|
|
FIO
1391
DELISTED
FUSION-IO INC COM
FIO
| $5.23M | ﹤0.01% |
+367,220
| New | +$5.52M |
|
1392
ICU Medical
ICUI
$4.58B
| $5.22M | ﹤0.01% |
+72,500
| New | +$4.79M |
|
|
BZC
1393
DELISTED
BREEZE-EASTERN CORPORATION COM
BZC
| $5.21M | ﹤0.01% |
+591,797
| New | +$5.03M |
|
1394
Children's Place
PLCE
$55.1M
| $5.17M | ﹤0.01% |
+94,350
| New | +$4.76M |
|
|
STRZA
1395
DELISTED
Starz - Series A
STRZA
| $5.16M | ﹤0.01% |
+233,550
| New | +$5.25M |
|
1396
Dana Inc
DAN
$3.2B
| $5.13M | ﹤0.01% |
+266,500
| New | +$4.72M |
|
|
OREX
1397
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $5.06M | ﹤0.01% |
+86,570
| New | +$5.33M |
|
|
EV
1398
DELISTED
Eaton Vance Corp.
EV
| $5.05M | ﹤0.01% |
+134,266
| New | +$5.4M |
|
|
CYBE
1399
DELISTED
Cyberoptics Corp
CYBE
| $4.99M | ﹤0.01% |
+858,230
| New | +$5.08M |
|
|
DM
1400
DELISTED
DOLAN COMPANY COMMON STOCK
DM
| $4.97M | ﹤0.01% |
+3,050,606
| New | +$5.45M |
|
Similar funds
T. Rowe Price Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for T. Rowe Price Associates, which disclosed 2,429 positions worth $374B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2013 buy was Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $374B portfolio in Q2 2013.
- T. Rowe Price Associates disclosed 2,429 positions in Q2 2013, its first 13F filing on record.
Based on T. Rowe Price Associates's 13F filing for Q2 2013, filed 14 Aug 2013.